Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cambridge Crystallographic Data Centre (CCDC) and Rutgers Partner

Published: Monday, November 04, 2013
Last Updated: Monday, November 04, 2013
Bookmark and Share
New partnership sees the CCDC establish operations in North America housed within the CIPR alongside the RCSB Protein Data Bank.

Coincident with formation of this new partnership is the launch of CCDC Inc., which will serve the CCDC’s user communities across North America. The new CCDC organization will collaborate with scientists at the RCSB Protein Data Bank and the Center for Integrative Proteomics Research (CIPR) to develop and implement new integrated approaches to scientific discovery, working closely with academic and industrial partners.

The Cambridge Crystallographic Data Centre compiles and distributes the Cambridge Structural Database (CSD), the world’s only comprehensive resource for small molecule crystal structure data, to more than 1,200 academic and 200 commercial organizations worldwide. Approximately half of the members of the CCDC’s user communities are based in North America. The new CCDC Inc. operation at Rutgers will bring expert application science support in the areas of small molecule crystallography, drug discovery and development, and materials science directly to the CCDC’s user communities throughout North America. Paul Davie has been appointed to head the new operations, becoming General Manager of CCDC Inc.

The Center for Integrative Proteomics Research is a new 75,000-square-foot facility on Rutgers' Busch Campus dedicated to fostering interdisciplinary structure-function studies of complex biomolecular phenomena. Center members include internationally recognized Rutgers faculty, leading research groups focused on computational chemistry, structural biology, mechanistic enzymology, and bioinformatics. The Center is the home of the RCSB Protein Data Bank. In addition, the CIPR serves as headquarters of the BioMaPS Institute for Quantitative Biology, with its interdisciplinary Ph.D. program in Computational Biology and Molecular Biophysics, and houses core facilities for NMR spectroscopy, mass spectrometry, X-ray crystallography, and cryo-electron microscopy.

The Research Collaboratory for Structural Bioinformatics Protein Data Bank is a member of the wwPDB, which is responsible for managing the Protein Data Bank archive - the single global repository for experimental structures of biological macromolecules with nearly 100,000 entries.  The RCSB Protein Data Bank provides tools and educational materials worldwide for advancing research and education by curating, integrating, and disseminating biological macromolecular structural information in the context of biological function and processes, biochemical pathways, evolution, and disease. The Protein Data Bank archive is used intensively by many thousands of research scientists, teachers, and students around the world in studies of biology, biochemistry, and medicine.

Stephen K. Burley, Director of the CIPR, Associate Director of the RCSB Protein Data Bank, Director of BioMAPS, Distinguished Professor of Chemistry and Chemical Biology, and Member of the Rutgers Cancer Institute of New Jersey expressed his excitement about the new initiative, “My Center colleagues and I are delighted to welcome members of the CCDC to Rutgers. We look forward to a long and productive partnership, which will enhance our interdisciplinary research efforts on biomolecules large and small and deliver new synergies between the RCSB Protein Data Bank and the CCDC.”

Stephen K. Burley, Director of Rutgers' CIPR

Colin Groom, Executive Director of the CCDC made clear the importance of this new partnership by adding: “Research scientists in discovery seldom rely on small molecule or target structural information alone – they need reliable data in both areas, of course. This new collaboration with CIPR and the RCSB PDB will allow us to develop and implement new integrated approaches to discovery, based on the latest validated data from reliable sources. We hear continually from our partners about the importance of developing efficient workflows across data domains – this collaboration sees the potential of great steps forward towards this vision.”

S. David Kimball, Associate Vice President for Translational Science in the Rutgers Office of the Vice President of Research and Research Professor in the Ernest Mario School of Pharmacy, played a central role bringing the contractual arrangements to fruition in short order. He reflected on the broader impact of the new partnership by pointing out that “cooperative interactions between the CCDC and the Rutgers materials science community represent another important avenue for synergy.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
Crystals, Super Magnets in Drug Discovery
Scientists have produced larger superparamagnetic crystals that could revolutionise drug delivery.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Snapshots of Chemical Flipping a Biological Switch
X-ray laser gets first real-time snapshots of a chemical flipping a biological switch, opening new path to understanding how RNA works.
Uncovering Elusive Proteins
Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.
Cannabinoid Receptor Structure Revealed
Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Study Unocovers Cancer-Linked Protein’s Associates
Researchers have developed a new list of nearly 100 potential partners of a cancer-linked enzyme by studying its interactions with other proteins.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!